Stemtech CorpOTCQB:STEK
- LAST PRICE0.0585
- TODAY'S CHANGE (%)0.0038 (6.9470%)
- Bid / Lots0.0383/ 100
- Ask / Lots0.0647/ 100
- Open / Previous Close0.0565 / 0.0547
- Day Range
- 52 Week Range
- Volume154,035
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | STEK |
|---|---|---|
| 09:32 ET | 51225 | 0.0565 |
| 09:37 ET | 17310 | 0.05475 |
| 09:39 ET | 391 | 0.055275 |
| 09:42 ET | 150 | 0.05475 |
| 09:46 ET | 900 | 0.053 |
| 09:48 ET | 24000 | 0.05475 |
| 09:50 ET | 6314 | 0.056325 |
| 09:57 ET | 6980 | 0.05545 |
| 10:18 ET | 1562 | 0.054225 |
| 10:29 ET | 2500 | 0.053 |
| 10:38 ET | 5000 | 0.05475 |
| 10:54 ET | 22221 | 0.0495 |
| 11:05 ET | 109 | 0.05275 |
| 11:30 ET | 700 | 0.05475 |
| 11:59 ET | 375 | 0.05475 |
| 12:24 ET | 400 | 0.055875 |
| 02:54 ET | 100 | 0.051 |
| 02:59 ET | 1400 | 0.051375 |
| 03:32 ET | 100 | 0.05475 |
| 03:39 ET | 12200 | 0.0585 |
Nov 20, 2024
Stemtech Corporation and Viago Announce Strategic Merger, from 9:30AM ET on Wednesday Nov 20, 2024 by Dow Jones
9:30AM ET on Wednesday Nov 20, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Stemtech Corp | 7.4M | -1.1x | --- |
Plus Therapeutics Inc | 7.0M | -0.5x | --- |
Evogene Ltd | 8.2M | -0.4x | --- |
Kineta Inc | 4.9M | -0.2x | --- |
InMed Pharmaceuticals Inc | 3.3M | -0.1x | --- |
COSCIENS Biopharma Inc | 11.1M | -0.4x | --- |
Company Information
Stemtech Corporation is a global network marketing company that develops science-based products, which support wellness by helping the body maintain healthy stem cell physiology, also known as stem cell enhancers. The Company is also known as Stem Cell Nutrition Company. The Company operates through three geographic segments: North America, Latin America, and Asia. The Company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. The Company’s products are marketed internationally by the Company’s subsidiaries and through independent distributors. The Company markets its products under various brands, which include RCM System, stemrelease3, Stemflo MigraStem and OraStem (Oral Health Care), and Cellect One Rapid Renew Stem Cell Peptide Night Cream.
Contact Information
- Headquarters
- 4851 Tamiami Trail North, Suite 200NAPLES, FL, United States 34103
- Phone
- 954-715-6000
- Fax
- 954-715-3333
Executives
- Chief Operating Officer, Director
- John Meyer
- Chief Executive Officer, Director
- Charles Arnold
- Chief Financial Officer
- James Cardwell
- Independent Director
- Darryl Green
- Independent Director
- Benjamin Kaplan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.4M |
|---|---|
Revenue (TTM) | $5.1M |
Shares Outstanding | 134.8M |
Stemtech Corp does not pay a dividend. | |
Beta | 2.55 |
EPS | $-0.05 |
Book Value | $-0.02 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -75.40% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
